Skip to Content

Logo 661 (Ropinirole Hydrochloride Extended-Release 12 mg)

Pill with imprint Logo 661 is Yellow, Elliptical / Oval and has been identified as Ropinirole Hydrochloride Extended-Release 12 mg. It is supplied by Actavis Elizabeth LLC.

Ropinirole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Ropinirole 12 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Logo 661

Ropinirole hydrochloride extended-release 12 mg Logo 661
Ropinirole hydrochloride extended-release 12 mg Logo 661
Ropinirole hydrochloride extended-release 12 mg Logo 661
Ropinirole hydrochloride extended-release 12 mg Logo 661

Ropinirole Hydrochloride Extended-Release

Imprint
Logo 661
Strength
12 mg
Color
Yellow
Size
16.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Dopaminergic antiparkinsonism agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Actavis Elizabeth LLC
Inactive Ingredients
silicon dioxide, croscarmellose sodium, castor oil, hypromelloses, lactose monohydrate, magnesium stearate, maltodextrin, titanium dioxide, ferric oxide yellow, polyethylene glycol, magnesium silicate

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00228-3661 Actavis Pharma, Inc.
42291-0717 AvKare, Inc.

Get help with Imprint Code FAQs.

Related Images for "Logo 661"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.